Effect of the IBAIP in Preterm Infants Neurodevelopment

Recruiting N/A Interventional Study
Premature Birth
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
25 Weeks – 32 Weeks
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
240 (estimated)
Sponsor
University Hospital, Brest · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Mortality in very preterm infants has decreased significantly over the past twenty years. However, neuromotor, behavioral and cognitive development disorders are more common in these children born before 33 weeks of gestation as compared to term born infants. These neurodevelopmental disorders include difficulties with self-regulation, tone, posture or poor quality movements as well as inadequate…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria : * Preterm infants born (including multiple pregnancies) at a gestational age between 25 weeks +0 days and 32 weeks + 6days. * Written informed consent of at least one of the parents / legal guardian or 2 parents / legal guardians depending on the family context * Normal neurolo…
Contacts

Jean-Michel ROUE, PhD

2.98.22.36.67

jean-michel.roue@chu-brest.fr

CONTACT